Frontlight ResearchEarly access
Lung cancer trials in France
316 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleEXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.
- Where
- Lille Cedex
- Age
- 18 years and over
- People
- 21
- Run by
- University Hospital, Lille
See details and how to joinNCT06448572 · EU 2023-505285-28-01 - No phaseTaking peopleImpact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 800
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07191171 - No phaseTaking peopleLIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
- Where
- Boulogne-Billancourt, Paris, Saint-Cloud
- Age
- 18 years and over
- People
- 300
- Run by
- Institut Curie
See details and how to joinNCT04790682 - No phaseTaking peopleDeciphering Mechanisms Underlying Cancer Immunogenicity
- Where
- Toulouse
- Age
- 18 years and over
- People
- 1,100
- Run by
- Institut Claudius Regaud
See details and how to joinNCT03958240 - No phaseTaking peopleInterest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection
- Where
- Caen, Rouen, Valenciennes
- Age
- 18 years and over
- People
- 184
- Run by
- University Hospital, Rouen
See details and how to joinNCT06202222 - No phaseTaking peopleMobile Lung Cancer Screening
- Where
- Pierre-Bénite
- Age
- 50 years to 75 years
- People
- 4,312
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07015151 - No phaseTaking peopleTumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
- Where
- Boulogne-Billancourt
- Age
- 18 years and over
- People
- 50
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04300062 - No phaseTaking peopleInflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study
- Where
- Tours
- Age
- 18 years and over
- People
- 150
- Run by
- University Hospital, Tours
See details and how to joinNCT07004868 - No phaseTaking peopleEMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients
- Where
- Nancy
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Hedera Dx SA
See details and how to joinNCT07096258 - No phaseNot yet taking people in FranceRole of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
- Where
- Bordeaux
- Age
- 18 years and over
- People
- 10
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT06024226 - No phaseNot yet taking people in FranceRole of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
- Where
- Bordeaux
- Age
- 18 years and over
- People
- 25
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT06024538 - No phaseNot yet taking people in FranceEffect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)
- Where
- Bordeaux
- Age
- 18 years and over
- People
- 30
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT06711770 - No phaseNot yet taking people in FranceTumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
- Where
- Montpellier
- Age
- 18 years and over
- People
- 72
- Run by
- University Hospital, Montpellier
See details and how to joinNCT06974097 - Phase 1/2Taking peopleFIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
- Where
- Marseille, Saint-Herblain, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06669117 · EU 2024-512760-64-00 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Brest Cedex 2, Lille, Lyon, Marseille, Paris Cedex 18, Rennes, Villejuif
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - Phase 3Taking peopleMaintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
- Where
- Albi, Auxerre, Bayonne, Béziers, Brest, Bron, Caen Cedex 5, Carcassonne, Cholet, Compiegne, Créteil, La Rochelle, Le Chesnay, Le Coudray, Lille, Lyon Cedex 04, Marseille, Mont de marsan, Morlaix, Mulhouse, Orléans, Paris, Pau, Pierre-Bénite, Rennes, Sain-Denis-Réunion, Saint-Etienne, Saint-Herblain Cedex, Saint-Malo, Saint-Mandé, Saint-Pierre - La Reunion, Strasbourg, Suresnes, Tarbes Cedex 9, Tours, Villejuif, Centre de Lutte contre le cancer PAUL STRAUSS (CPS)
- Age
- 18 years and over
- People
- 1,166 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05692999 · EU 2023-503481-23-00 - Phase 3Taking peopletislelizUMaB in canceR Patients With molEcuLar residuaL Disease
- Where
- Villejuif
- Age
- 18 years and over
- People
- 717
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06332274 - Phase 2Active, not recruitingSotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
- Where
- Créteil, Lyon, Paris Cedex 14, Paris Cedex 20, Villejuif
- Age
- 18 years and over
- People
- 40
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05631249 · EU 2024-510837-16-00 - No phaseTaking peopleGenotyping of Ebus-tbna Supernant Cell-free Dna in Nsclc
- Where
- Toulouse
- Age
- 18 years to 65 years
- People
- 50
- Run by
- University Hospital, Toulouse
See details and how to joinNCT04624373 - Phase 2/3Taking peopleDe-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
- Where
- Amiens, Angers, Argenteuil Cedex, Avignon, Besançon, Bordeaux Cedex, Boulogne-Billancourt, Caen Cedex 9, Cannes Cedex, Chauny, Clamart, Colmar Cedex, Dijon, Grasse, Grenoble Cedex 9, La Roche-sur-Yon, Le Chesnay Rocquencourt, Le Mans Cedex 9, Lille Cedex, Limoges, Lyon, Lyon Cedex 04, Marseille, Meaux, Montpellier, Morlaix, Mulhouse, Nantes, Nice, Nice Cedex 2, Orleans Cedex 2, Paris, Paris Cedex 20, Pau Cedex, Reims, Rouen Cedex, Saint-Cloud, Saint-Etienne, Saint-Nazaire, Saint-Priest-en-Jarez, Saint-Quentin, Strasbourg Cedex, Toulon, Toulouse, Tours, Valence, Vandoeuvre les Nancy, Vannes, Vantoux, CHU de La Réunion site Sud
- Age
- 18 years to 74 years
- People
- 1,360
- Run by
- Intergroupe Francophone de Cancerologie Thoracique
See details and how to joinNCT05255302 · EU 2024-515945-40-00 - No phaseTaking peopleClinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC
- Where
- Nice
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06111807 - Phase 1Not yet taking people in FrancePhase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer.
- Where
- Paris
- Age
- 18 years and over
- People
- 20
- Run by
- Transgene
See details and how to join2024-514001-65-00 - Phase 1/2Not yet taking people in FranceCisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
- Where
- Boulogne-Billancourt, Caen, Paris, Saint-Herblain
- Age
- 18 years and over
- People
- 32 worldwide
- Run by
- Inhatarget Therapeutics
See details and how to joinNCT06896890 - No phaseTaking peopleImpact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
- Where
- Dijon
- Age
- 18 months and over
- People
- 100
- Run by
- Centre Georges Francois Leclerc
See details and how to joinNCT05783908 - No phaseNot yet taking people in FranceIn-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients
- Where
- Marseille
- Age
- 18 years and over
- People
- 640
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06827639